About
Technology
Issues
FAQ
Links
Official Page
A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.